SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Sep 26, 2019

PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Sept. 26, 2019 · CIK: 0001624326 · Accession: 0000000000-19-013984

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-37685

Date
September 26, 2019
Author
Dennis M. McGrath
Form
UPLOAD
Company
PAVmed Inc. (PAVM) (CIK 0001624326)

Letter

September 26, 2019 Dennis M. McGrath Chief Financial Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, NY 10165 Re:PAVmed Inc. Form 10-K for the Fiscal Year Ended December 31, 2018 Filed April 1, 2019 File No. 001-37685 Dear Mr. McGrath: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this comment, we may have additional comments. Form 10-K for the Fiscal Year Ended December 31, 2018 Exhibits, page 51 1.We note that the certifications filed as Exhibits 31.1 and 31.2 exclude the introductory language regarding internal control over financial reporting in the fourth paragraph. Please amend the filing to provide revised certifications that include the required information. You may file an abbreviated amendment that is limited to the cover page, explanatory note, signature page and paragraphs 1, 2, 4 and 5 of the certifications. Refer to Exchange Act Rule 13a-14(a) and Item 601(b)(31) of Regulation S-K. This comment also applies to your Forms 10-Q for the quarterly periods ended March 31, 2019 and June 30, 2019.

FirstName LastNameDennis M. McGrath Comapany NamePAVmed Inc. September 26, 2019 Page 2 FirstName LastName Dennis M. McGrath PAVmed Inc. September 26, 2019 Page 2 In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Eric Atallah at (202) 551-3663 or Tara Harkins, Senior Accountant, at (202) 551-3639 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery

Show Raw Text
September 26, 2019
Dennis M. McGrath
Chief Financial Officer
PAVmed Inc.
One Grand Central Place, Suite 4600
New York, NY 10165
Re:PAVmed Inc.
Form 10-K for the Fiscal Year Ended December 31, 2018
Filed April 1, 2019
File No. 001-37685
Dear Mr. McGrath:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comment.  In our comment, we may ask you to provide us
with information so we may better understand your disclosure.
            Please respond to this comment within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this comment, we may have additional comments.
Form 10-K for the Fiscal Year Ended December 31, 2018
Exhibits, page 51
1.We note that the certifications filed as Exhibits 31.1 and 31.2 exclude the introductory
language regarding internal control over financial reporting in the fourth
paragraph.  Please amend the filing to provide revised certifications that include the
required information. You may file an abbreviated amendment that is limited to the cover
page, explanatory note, signature page and paragraphs 1, 2, 4 and 5 of the certifications.
Refer to Exchange Act Rule 13a-14(a) and Item 601(b)(31) of Regulation S-K.  This
comment also applies to your Forms 10-Q for the quarterly periods ended March 31, 2019
and June 30, 2019.

 FirstName LastNameDennis M. McGrath
 Comapany NamePAVmed Inc.
 September 26, 2019 Page 2
 FirstName LastName
Dennis M. McGrath
PAVmed Inc.
September 26, 2019
Page 2
            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            You may contact Eric Atallah at (202) 551-3663 or Tara Harkins, Senior Accountant, at
(202) 551-3639 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery